Published in J Virol on December 01, 1992
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release. Proc Natl Acad Sci U S A (2002) 1.42
A viral nonstructural protein regulates bluetongue virus trafficking and release. J Virol (2009) 1.39
Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol (2006) 1.30
Bluetongue virus: dissection of the polymerase complex. J Gen Virol (2008) 1.17
Membrane organization of bluetongue virus nonstructural glycoprotein NS3. J Virol (1998) 1.05
Interaction of calpactin light chain (S100A10/p11) and a viral NS protein is essential for intracellular trafficking of nonenveloped bluetongue virus. J Virol (2011) 1.01
Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. J Virol (1996) 0.96
Bluetongue virus nonstructural protein NS3/NS3a is not essential for virus replication. PLoS One (2014) 0.93
Drosophila melanogaster as a model organism for bluetongue virus replication and tropism. J Virol (2012) 0.93
Deletion and mutational analyses of bluetongue virus NS2 protein indicate that the amino but not the carboxy terminus of the protein is critical for RNA-protein interactions. J Virol (1994) 0.88
Role of lipids on entry and exit of bluetongue virus, a complex non-enveloped virus. Viruses (2010) 0.86
Bluetongue virus capsid assembly and maturation. Viruses (2014) 0.85
Cellular phosphoinositides and the maturation of bluetongue virus, a non-enveloped capsid virus. Virol J (2013) 0.81
RNA elements in open reading frames of the bluetongue virus genome are essential for virus replication. PLoS One (2014) 0.80
Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis. Parasit Vectors (2015) 0.78
Turnover Rate of NS3 Proteins Modulates Bluetongue Virus Replication Kinetics in a Host-Specific Manner. J Virol (2015) 0.77
Oncolytic bluetongue viruses: promise, progress, and perspectives. Front Microbiol (2011) 0.76
The effect of glycosylation on cytotoxicity of Ibaraki virus nonstructural protein NS3. J Vet Med Sci (2015) 0.75
Influence of cellular trafficking pathway on bluetongue virus infection in ovine cells. Viruses (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res (1987) 36.83
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem (1985) 26.05
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol (1991) 12.00
Bifunctional messenger RNAs in eukaryotes. Cell (1986) 6.18
Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry (1985) 4.86
Regulation of protein export from the endoplasmic reticulum. Annu Rev Cell Biol (1988) 4.53
Protein glycosylation in yeast. Annu Rev Biochem (1987) 3.32
Structure of the bluetongue virus capsid. J Virol (1972) 3.27
Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem (1991) 3.01
Optimizing hydrolysis of N-linked high-mannose oligosaccharides by endo-beta-N-acetylglucosaminidase H. Anal Biochem (1984) 2.98
Regulation of protein synthesis in virus-infected animal cells. Adv Virus Res (1986) 2.93
A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol (1985) 2.78
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology (1984) 2.60
Receptor activity of rotavirus nonstructural glycoprotein NS28. J Virol (1989) 2.09
Glycosylation allows cell-surface transport of an anchored secretory protein. Cell (1985) 2.06
Interaction of rotavirus cores with the nonstructural glycoprotein NS28. Virology (1989) 1.83
Characterization of the tubules associated with the replication of three different orbiviruses. Virology (1979) 1.65
Two types of glycoprotein precursors are produced by the simian rotavirus SA11. Virology (1983) 1.57
Effect of mutations and deletions in a bicistronic mRNA on the synthesis of influenza B virus NB and NA glycoproteins. J Virol (1989) 1.50
Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. Biochim Biophys Acta (1985) 1.40
Three-dimensional structure of single-shelled bluetongue virus. J Virol (1992) 1.35
Nucleotide sequence of a cDNA clone of RNA segment 10 of bluetongue virus (serotype 10). J Gen Virol (1986) 1.34
Protein synthesis in bluetongue virus-infected cells. Virology (1979) 1.34
Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins. Virology (1991) 1.29
Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10. J Virol (1988) 1.27
The human erythrocyte anion-transport protein. Partial amino acid sequence, conformation and a possible molecular mechanism for anion exchange. Biochem J (1983) 1.27
Structure of branched lactosaminoglycan, the carbohydrate moiety of band 3 isolated from adult human erythrocytes. J Biol Chem (1984) 1.27
Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy. Virology (1992) 1.26
Synthesis of bluetongue virus-encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single-stranded RNA species. J Gen Virol (1990) 1.24
A membrane-anchored form but not the secretory form of human chorionic gonadotropin-alpha chain acquires polylactosaminoglycan. J Biol Chem (1988) 1.23
The replication of bluetongue virus. Curr Top Microbiol Immunol (1990) 1.20
Polylactosaminoglycan modification of a small integral membrane glycoprotein, influenza B virus NB. Mol Cell Biol (1988) 1.18
Localization of the non-structural protein NS3 in bluetongue virus-infected cells. J Gen Virol (1991) 1.13
Structure of the bluetongue virus genome and its encoded proteins. Curr Top Microbiol Immunol (1990) 1.08
Structures of sialylated fucosyl polylactosaminoglycans isolated from chronic myelogenous leukemia cells. J Biol Chem (1985) 1.01
Nucleotide sequence of the Australian bluetongue virus serotype 1 RNA segment 10. J Gen Virol (1988) 0.97
Comparison of the nonstructural protein, NS3, of tick-borne and insect-borne orbiviruses. Virology (1992) 0.86
High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA. Virus Res (1991) 0.85
A comparison of the genes which encode non-structural protein NS3 of different orbiviruses. J Gen Virol (1991) 0.80
Secretion of N-glycosylated human recombinant interleukin-1 alpha in Saccharomyces cerevisiae. Gene (1990) 0.78
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology (1972) 4.05
An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology (1966) 4.03
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
The membrane structure of lipid-containing viruses. Biochim Biophys Acta (1974) 3.92
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase. J Virol (1972) 3.84
Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol (1995) 3.82
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol (1976) 3.61
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Endotracheal/endobronchial metastases : clinicopathologic study with special reference to developmental modes. Chest (2001) 3.57
Properties of the product synthesized by vesicular stomatitis virus particles. J Mol Biol (1971) 3.55
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol (1992) 3.20
Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci U S A (1991) 3.18
Structure of the ribonucleoprotein of influenza virus. J Virol (1972) 3.11
Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J (1986) 3.00
Assembly of animal viruses at cellular membranes. Annu Rev Microbiol (1988) 2.99
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian J Ophthalmol (2001) 2.96
Kinetics of RNA synthesis by vesicular stomatitis virus particles. J Mol Biol (1971) 2.86
Genome homology of vesicular stomatitis virus and defective T particles and evidence for the sequential transcription of the virion ribonucleic acid. J Virol (1972) 2.70
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol (1996) 2.63
Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology (1997) 2.61
Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (1995) 2.59
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1995) 2.57
Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell (1983) 2.54
Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol (1995) 2.50
Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5. Proc Natl Acad Sci U S A (1967) 2.46
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology (1998) 2.43
Increased prevalence of hypertension and long-term arsenic exposure. Hypertension (1995) 2.36
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J Virol (1992) 2.36
Location of the glycoprotein in the membrane of Sindbis virus. Nat New Biol (1971) 2.35
Abdominal tuberculosis. Diagnosis by fine needle aspiration cytology. Acta Cytol (1993) 2.26
Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology (1993) 2.23
Late messenger RNA production by viable simian virus 40 mutants with deletions in the leader region. J Mol Biol (1981) 2.18
Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol (1994) 2.17
Complete sequence of bluetongue virus L2 RNA that codes for the antigen recognized by neutralizing antibodies. J Virol (1985) 2.17
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol (2003) 2.16
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol (1993) 2.16
Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J (1998) 2.15
Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins. Virology (1978) 2.13
Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nat Med (1997) 2.13
The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol (1990) 2.11
Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol (2000) 2.11
Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc Natl Acad Sci U S A (1993) 2.10
Polarity of influenza and vesicular stomatitis virus maturation in MDCK cells: lack of a requirement for glycosylation of viral glycoproteins. Proc Natl Acad Sci U S A (1979) 2.09
Lymphangiomas of the oral cavity: a clinicopathologic, immunohistochemical, and electron-microscopic study. J Oral Maxillofac Surg (1997) 2.07
Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol (1994) 2.00
Influenza virus proteins. II. Association with components of the cytoplasm. Virology (1973) 1.98
Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology (1996) 1.95
Initiation and direction of RNA transcription by vesicular stomatitis virus virion transcriptase. J Virol (1973) 1.95
Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study. Cancer (1999) 1.92
HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem (1993) 1.91
Detection of homologous RNA sequences among six rhabdovirus genomes. J Virol (1974) 1.91
Basolateral maturation of retroviruses in polarized epithelial cells. J Virol (1983) 1.90
An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. Virology (1970) 1.88
Isolation and properties of poliovirus minus strand ribonucleic acid. J Virol (1970) 1.88
Identification of the spike proteins of Rous sarcoma virus. Virology (1971) 1.87
Protection against vaginal SIV transmission with microencapsulated vaccine. Science (1993) 1.86
Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J Virol (1970) 1.85
Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem (2001) 1.82
Host cell dependence of viral morphology. Proc Natl Acad Sci U S A (1998) 1.78
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J Virol (1990) 1.78
RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins. Proc Natl Acad Sci U S A (1991) 1.74
Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol (1995) 1.73
Murine model for evaluation of protective immunity to influenza virus. Vaccine (1993) 1.73
Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol (1997) 1.71
Unspliced functional late 19S mRNAs containing intervening sequences are produced by a late leader mutant of simian virus 40. Proc Natl Acad Sci U S A (1981) 1.71
Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells. Mol Cell Biol (1985) 1.69
Regulation of the late events in flavivirus protein processing and maturation. Virology (1993) 1.68
Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J Virol (1989) 1.66
Plasmacytoma of the oral cavity and jaws: a clinicopathologic study of 13 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.66
An electron microscopic study of single-cycle infection of chick embryo fibroblasts by influenza virus. Virology (1969) 1.65
The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc Natl Acad Sci U S A (1995) 1.65
Manganese in infant formulas and learning disability. Ann Nutr Metab (1983) 1.64
A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol (1990) 1.64
The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol (1991) 1.64
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng (2001) 1.64
12-month Tai Chi training in the elderly: its effect on health fitness. Med Sci Sports Exerc (1998) 1.64
Selective vulnerability of embryonic cell populations to ethanol-induced apoptosis: implications for alcohol-related birth defects and neurodevelopmental disorder. Alcohol Clin Exp Res (2001) 1.63
Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. J Gen Virol (1971) 1.62
The crystal structure of bluetongue virus VP7. Nature (1995) 1.61
In vivo engineering of metabolically active hepatic tissues in a neovascularized subcutaneous cavity. Am J Transplant (2006) 1.61
Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol (1989) 1.59
Behaviour of Chrysomya megacephala (Fabr.) and Hemipyrellia ligurriens (Wied.) as parasites of living animals under experimental conditions. S Afr J Med Sci (1971) 1.59
Complete sequence of the NS1 gene (M6 RNA) of US bluetongue virus serotype 10. Nucleic Acids Res (1987) 1.59
Bone morphogenesis in implants of insoluble bone gelatin. Proc Natl Acad Sci U S A (1973) 1.59
[Relationship between chilliness of the limbs and daily-life conditions in young females]. Nihon Eiseigaku Zasshi (1995) 1.57
The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. Virology (1990) 1.57
Spin-labeled electron spin resonance study of the lipid-containing membrane of influenza virus. Proc Natl Acad Sci U S A (1971) 1.57
Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza A viruses. Virology (1979) 1.56
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer. Ann Oncol (2011) 1.54
Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem (1992) 1.53
Varus derotation osteotomy for persistent dysplasia in congenital dislocation of the hip. Proximal femoral growth and alignment changes in the leg. J Bone Joint Surg Br (1995) 1.53